Page last updated: 2024-11-01

omeprazole and Colitis

omeprazole has been researched along with Colitis in 13 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.

Research Excerpts

ExcerptRelevanceReference
"A 57-year-old man developed chronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease."7.73Lansoprazole-associated collagenous colitis: a case report. ( Höbling, W; Kirchgatterer, A; Knoflach, P; Rammer, M, 2005)
"To clarify the effector sites of lansoprazole in the colonic mucosa during the formation of colitis, dextran sulfate sodium-induced colitis was induced by the oral administration of 3% aqueous solution for 3 and 7 days."7.73Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis. ( Arakawa, T; Asada, M; Atsuda, K; Hibi, N; Higuchi, K; Matsui, H; Nakamura, M; Tsuchimoto, K; Watanabe, T, 2005)
"To clarify the microvascular changes and the effector sites of lansoprazole during the formation of colitis, the dextran sulfate sodium (DSS)-induced colitis was induced by the oral administration for 3 and 7 days."7.73Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites. ( Asada, M; Hibi, N; Inoue, J; Matsui, H; Nakamura, M; Oda, M; Tsuchimoto, K, 2006)
"A patient is described who developed clinical and pathologic findings of collagenous colitis during treatment with lansoprazole and omeprazole."7.71Collagenous colitis associated with lansoprazole. ( Mattia, A; Wilcox, GM, 2002)
"We report two cases of lymphocytic colitis with severe diarrhea in patients treated by lansoprazole for six weeks."7.70[lymphocytic colitis associated with lansoprazole treatment]. ( De Maeght, S; Gerard, R; Ghilain, JM; Henrion, J; Maisin, JM; Piron, A; Schapira, M, 2000)
"The authors report the case of a patient suffering from collagen colitis in whom the administration of omeprazole achieved the rapid and total abolition of the clinical signs and a significant reduction of the collagen band (measurements determined over 10 cryptic spaces using a graduated micrometric ocular microscope)."7.68[Value of omeprazole in the treatment of collagenous colitis]. ( Abinader, J; Becot, F; Carre, JL; Monnet, D; Piquemal, A; Roblin, X, 1991)
"Lansoprazole is a proton pump inhibitor widely prescribed for gastroesophageal reflux and benign peptic ulcer disease."5.32Diarrhea associated with lansoprazole. ( Mukherjee, S, 2003)
"Lansoprazole is a potent proton pump inhibitor that has been well tolerated with minimal serious adverse events."5.31Lansoprazole-associated microscopic colitis: a case series. ( Bensen, SP; Lestina, LS; Maheshwari, Y; Ratcliffe, NR; Thomson, RD; Toor, A, 2002)
"A 57-year-old man developed chronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease."3.73Lansoprazole-associated collagenous colitis: a case report. ( Höbling, W; Kirchgatterer, A; Knoflach, P; Rammer, M, 2005)
"To clarify the effector sites of lansoprazole in the colonic mucosa during the formation of colitis, dextran sulfate sodium-induced colitis was induced by the oral administration of 3% aqueous solution for 3 and 7 days."3.73Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis. ( Arakawa, T; Asada, M; Atsuda, K; Hibi, N; Higuchi, K; Matsui, H; Nakamura, M; Tsuchimoto, K; Watanabe, T, 2005)
"To clarify the microvascular changes and the effector sites of lansoprazole during the formation of colitis, the dextran sulfate sodium (DSS)-induced colitis was induced by the oral administration for 3 and 7 days."3.73Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites. ( Asada, M; Hibi, N; Inoue, J; Matsui, H; Nakamura, M; Oda, M; Tsuchimoto, K, 2006)
"A patient is described who developed clinical and pathologic findings of collagenous colitis during treatment with lansoprazole and omeprazole."3.71Collagenous colitis associated with lansoprazole. ( Mattia, A; Wilcox, GM, 2002)
"We report two cases of lymphocytic colitis with severe diarrhea in patients treated by lansoprazole for six weeks."3.70[lymphocytic colitis associated with lansoprazole treatment]. ( De Maeght, S; Gerard, R; Ghilain, JM; Henrion, J; Maisin, JM; Piron, A; Schapira, M, 2000)
"Omeprazole, 10 mg/kg, was given i."1.36Novel application of proton pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression. ( Chung, JW; Hahm, KB; Hong, KS; Kim, JH; Kim, YJ; Lee, JS, 2010)
"Lansoprazole is a proton pump inhibitor widely prescribed for gastroesophageal reflux and benign peptic ulcer disease."1.32Diarrhea associated with lansoprazole. ( Mukherjee, S, 2003)
"Lansoprazole is a potent proton pump inhibitor that has been well tolerated with minimal serious adverse events."1.31Lansoprazole-associated microscopic colitis: a case series. ( Bensen, SP; Lestina, LS; Maheshwari, Y; Ratcliffe, NR; Thomson, RD; Toor, A, 2002)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (15.38)18.2507
2000's10 (76.92)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, YJ1
Lee, JS1
Hong, KS1
Chung, JW1
Kim, JH1
Hahm, KB1
Thomson, RD1
Lestina, LS1
Bensen, SP1
Toor, A1
Maheshwari, Y1
Ratcliffe, NR1
Mukherjee, S1
Rammer, M1
Kirchgatterer, A1
Höbling, W1
Knoflach, P1
Nakamura, M2
Asada, M2
Atsuda, K1
Matsui, H2
Watanabe, T1
Higuchi, K1
Arakawa, T1
Hibi, N2
Tsuchimoto, K2
Inoue, J1
Oda, M1
Ottewell, PD1
Duckworth, CA1
Varro, A1
Dimaline, R1
Wang, TC1
Watson, AJ1
Dockray, GJ1
Pritchard, DM1
Pallarés Manrique, H1
García Montes, MJ1
Díaz Cano, S1
Barranco Jiménez, M1
Delgado Bellido, D1
Herrerías Gutiérrez, JM1
Ghilain, JM1
Schapira, M1
Maisin, JM1
De Maeght, S1
Piron, A1
Gerard, R1
Henrion, J1
Wilcox, GM1
Mattia, A1
Macaigne, G1
Boivin, JF1
Simon, P1
Chayette, C1
Cheaib, S1
Deplus, R1
Narayani, RI1
Burton, MP1
Young, GS1
Roblin, X1
Becot, F1
Abinader, J1
Piquemal, A1
Monnet, D1
Carre, JL1

Other Studies

13 other studies available for omeprazole and Colitis

ArticleYear
Novel application of proton pump inhibitor for the prevention of colitis-induced colorectal carcinogenesis beyond acid suppression.
    Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:8

    Topics: Animals; Carcinoma; Cell Transformation, Neoplastic; Colitis; Colorectal Neoplasms; Disease Models,

2010
Lansoprazole-associated microscopic colitis: a case series.
    The American journal of gastroenterology, 2002, Volume: 97, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Colitis; Co

2002
Diarrhea associated with lansoprazole.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Colitis; Colonoscopy; Diarrhea; Gastroin

2003
Lansoprazole-associated collagenous colitis: a case report.
    Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biopsy; Colitis; Collagen; Colonoscopy; Diagnosis, Differen

2005
Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis.
    Inflammopharmacology, 2005, Volume: 13, Issue:1-3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Infective Agents; Apoptosis; Autoradiography;

2005
Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites.
    Clinical hemorheology and microcirculation, 2006, Volume: 34, Issue:1-2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Binding Sites; Capillary Permeability; Colitis; Cy

2006
Gastrin increases murine intestinal crypt regeneration following injury.
    Gastroenterology, 2006, Volume: 130, Issue:4

    Topics: Animals; Benzodiazepinones; Cell Line; Cell Proliferation; Colitis; Dextran Sulfate; Enteritis; Enzy

2006
[Collagenous colitis].
    Revista clinica espanola, 1993, Volume: 193, Issue:7

    Topics: Adrenal Cortex Hormones; Adult; Colitis; Collagen Diseases; Diarrhea; Female; Humans; Middle Aged; O

1993
[lymphocytic colitis associated with lansoprazole treatment].
    Gastroenterologie clinique et biologique, 2000, Volume: 24, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Colitis; Diarrhea; Humans; Intestinal Mu

2000
Collagenous colitis associated with lansoprazole.
    Journal of clinical gastroenterology, 2002, Volume: 34, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Colitis; Collagen; Female; Humans; Lanso

2002
[Lansoprazole-associated collagenous colitis].
    Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Colitis; Collagen; Female; Gastroesophageal Reflux;

2001
Resolution of collagenous colitis after treatment for Helicobacter pylori.
    The American journal of gastroenterology, 2002, Volume: 97, Issue:2

    Topics: Aged; Biopsy, Needle; Clarithromycin; Colitis; Collagen; Diarrhea; Drug Therapy, Combination; Female

2002
[Value of omeprazole in the treatment of collagenous colitis].
    Annales de gastroenterologie et d'hepatologie, 1991, Volume: 27, Issue:4

    Topics: Administration, Oral; Colitis; Humans; Male; Middle Aged; Omeprazole

1991